Pelthos Therapeutics Inc.
General ticker "PTHS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $19.7M (TTM average)
Pelthos Therapeutics Inc. follows the US Stock Market performance with the rate: 41.4%.
Estimated limits based on current volatility of 6.1%: low 21.05$, high 23.79$
Short-term PTHS quotes
Long-term PTHS plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $2.32MM | $6.86MM | $7.57MM |
| Operating Income | $-2.32MM | $-6.86MM | $-7.57MM |
| Non-Operating Income | $-0.14MM | $-0.52MM | $-0.38MM |
| Interest Expense | $0.14MM | $0.52MM | $0.79MM |
| R&D Expense | $0.39MM | $2.58MM | $1.18MM |
| Income(Loss) | $-2.46MM | $-7.38MM | $-7.96MM |
| Profit(Loss)* | $-2.46MM | $-7.38MM | $-7.96MM |
| Stockholders Equity | $-3.71MM | $-6.44MM | $-2.71MM |
| Assets | $0.06MM | $0.10MM | $1.37MM |
| Operating Cash Flow | $-1.57MM | $-0.98MM | $-5.79MM |
| Financing Cash Flow | $1.62MM | $1.02MM | $6.21MM |
| Earnings Per Share** | $-4.26 | $-12.80 | $-13.54 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.